Phibro Animal Financials
| PAHC Stock | USD 22.25 0.15 0.68% |
Phibro |
Please note, the presentation of Phibro Animal's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Phibro Animal's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Phibro Animal's management manipulating its earnings.
Phibro Animal Stock Summary
Phibro Animal competes with Pacira BioSciences,, Dr Reddys, Collegium Pharmaceutical, ANI Pharmaceuticals, and Procaps Group. Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for food and companion animals. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey. Phibro Anl operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 1860 people.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US71742Q1067 |
| CUSIP | 71742Q106 |
| Location | New Jersey; U.S.A |
| Business Address | Glenpointe Centre East, |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.pahc.com |
| Phone | 201 329 7300 |
| Currency | USD - US Dollar |
Phibro Animal Key Financial Ratios
| Return On Equity | 0.0746 | ||||
| Return On Asset | 0.056 | ||||
| Target Price | 21.0 | ||||
| Beta | 0.52 | ||||
| Last Dividend Paid | 0.48 |
Phibro Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Phibro Animal's current stock value. Our valuation model uses many indicators to compare Phibro Animal value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Phibro Animal competition to find correlations between indicators driving Phibro Animal's intrinsic value. More Info.Phibro Animal Health is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers reporting about 0.75 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Phibro Animal Health is roughly 1.33 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Phibro Animal's earnings, one of the primary drivers of an investment's value.Phibro Animal Health Systematic Risk
Phibro Animal's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Phibro Animal volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Phibro Animal Health correlated with the market. If Beta is less than 0 Phibro Animal generally moves in the opposite direction as compared to the market. If Phibro Animal Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Phibro Animal Health is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Phibro Animal is generally in the same direction as the market. If Beta > 1 Phibro Animal moves generally in the same direction as, but more than the movement of the benchmark.
About Phibro Animal Financials
What exactly are Phibro Animal Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Phibro Animal's income statement, its balance sheet, and the statement of cash flows. Potential Phibro Animal investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Phibro Animal investors may use each financial statement separately, they are all related. The changes in Phibro Animal's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Phibro Animal's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Phibro Animal February 26, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Phibro Animal help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Phibro Animal Health. We use our internally-developed statistical techniques to arrive at the intrinsic value of Phibro Animal Health based on widely used predictive technical indicators. In general, we focus on analyzing Phibro Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Phibro Animal's daily price indicators and compare them against related drivers.
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 17.07 | |||
| Value At Risk | (5.82) | |||
| Potential Upside | 3.87 |
Complementary Tools for Phibro Stock analysis
When running Phibro Animal's price analysis, check to measure Phibro Animal's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Phibro Animal is operating at the current time. Most of Phibro Animal's value examination focuses on studying past and present price action to predict the probability of Phibro Animal's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Phibro Animal's price. Additionally, you may evaluate how the addition of Phibro Animal to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |